- Country: Germany
- Summary: Announcement on Pharmaceutical Frame Discount Contracts According to §130A Paragraph 8 Sgb V
- DET Ref No: 126460020
- Deadline: 10 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 606297-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the tender is the conclusion of pharmaceutical framework advances according to §130a paragraph 8 SGB V for the pension of drugs of the insured persons of the health insurance companies involved in this tender. 06/30/2028.
M03BX01
ATC Who: l01ea02
C01BD07
WHO: J02AC01
S01E01
N 05530
Active ingredient metformin and sitagliptin ATC Who: A10BD07
MethodCARBAMOL ATC Who: M03BA03
Active ingredient Olmesartanmedoxomil ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAnnouncement on Pharmaceutical Frame Discount Contracts According to §130A Paragraph 8 Sgb V - Germany Tender
The COMMERCIAL HEALTH INSURANCE COMPANY - KKH, a Government sector organization in Germany, has announced a new tender for Announcement on Pharmaceutical Frame Discount Contracts According to §130A Paragraph 8 Sgb V. This tender is published on GermanyTenders under DET Ref No: 126460020 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
